Boston Scientific Corporation (BSX)
NYSE: BSX · Real-Time Price · USD
91.45
+0.38 (0.42%)
At close: Dec 26, 2024, 4:00 PM
91.42
-0.03 (-0.03%)
Pre-market: Dec 27, 2024, 7:31 AM EST
Boston Scientific Employees
Boston Scientific had 48,000 employees as of December 31, 2023. The number of employees increased by 3,000 or 6.67% compared to the previous year.
Employees
48,000
Change (1Y)
3,000
Growth (1Y)
6.67%
Revenue / Employee
$331,479
Profits / Employee
$37,354
Market Cap
134.78B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 48,000 | 3,000 | 6.67% |
Dec 31, 2022 | 45,000 | 4,000 | 9.76% |
Dec 31, 2021 | 41,000 | 3,000 | 7.89% |
Dec 31, 2020 | 38,000 | 2,000 | 5.56% |
Dec 31, 2019 | 36,000 | 4,000 | 12.50% |
Dec 31, 2018 | 32,000 | 3,000 | 10.34% |
Dec 31, 2017 | 29,000 | 2,000 | 7.41% |
Dec 31, 2016 | 27,000 | 2,000 | 8.00% |
Dec 31, 2015 | 25,000 | 1,000 | 4.17% |
Dec 31, 2014 | 24,000 | 1,000 | 4.35% |
Dec 31, 2013 | 23,000 | -1,000 | -4.17% |
Dec 31, 2012 | 24,000 | 0 | - |
Dec 31, 2011 | 24,000 | -1,000 | -4.00% |
Dec 31, 2010 | 25,000 | -1,000 | -3.85% |
Dec 31, 2009 | 26,000 | 1,200 | 4.84% |
Dec 31, 2008 | 24,800 | -2,700 | -9.82% |
Dec 31, 2007 | 27,500 | -1,100 | -3.85% |
Dec 31, 2006 | 28,600 | 8,800 | 44.44% |
Dec 31, 2005 | 19,800 | 2,300 | 13.14% |
Dec 31, 2004 | 17,500 | 2,500 | 16.67% |
Dec 31, 2003 | 15,000 | 1,100 | 7.91% |
Dec 31, 2002 | 13,900 | -500 | -3.47% |
Dec 31, 2001 | 14,400 | 680 | 4.96% |
Dec 31, 2000 | 13,720 | 1,105 | 8.76% |
Dec 31, 1999 | 12,615 | -1,385 | -9.89% |
Dec 31, 1998 | 14,000 | 3,000 | 27.27% |
Dec 31, 1997 | 11,000 | 1,420 | 14.82% |
Dec 31, 1996 | 9,580 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Medtronic | 95,000 |
Pfizer | 88,000 |
Sanofi | 86,088 |
Danaher | 63,000 |
Bristol-Myers Squibb Company | 34,100 |
Amgen | 26,700 |
Stryker | 26,700 |
Gilead Sciences | 18,000 |
BSX News
- 8 days ago - FDA classifies recall of Boston Scientific catheters as 'most serious' - Reuters
- 15 days ago - Boston Scientific CMO Discuss Solutions for Health Inequality on Today's Marketplace - PRNewsWire
- 4 weeks ago - The Best Large-Cap Stocks to Buy - Kiplinger
- 4 weeks ago - Boston Scientific Announces Agreement to Acquire Intera Oncology® Inc. - PRNewsWire
- 5 weeks ago - Why Is Medical Device Giant Boston Scientific Stock Trading Higher On Monday? - Benzinga
- 5 weeks ago - Boston Scientific WATCHMAN FLX™ Left Atrial Appendage Closure Device Demonstrates Superior Bleeding Risk Reduction to Oral Anticoagulation Following a Cardiac Ablation in the OPTION Clinical Trial - PRNewsWire
- 5 weeks ago - Boston Scientific Corporation (BSX) UBS Global Healthcare Conference (Transcript) - Seeking Alpha
- 5 weeks ago - Boston Scientific Closes Acquisition of Axonics, Inc. - PRNewsWire